Ozols J, Caron J M
Department of Biochemistry, University of Connecticut Health Center, Farmington 06030, USA.
Mol Biol Cell. 1997 Apr;8(4):637-45. doi: 10.1091/mbc.8.4.637.
As shown in the companion article, tubulin is posttranslationally modified in vivo by palmitoylation. Our goal in this study was to identify the palmitoylation sites by protein structure analysis. To obtain quantities of palmitoylated tubulin required for this analysis, a cell-free system for enzymatic [3H]palmitoylation was developed and characterized in our companion article. We then developed a methodology to examine directly the palmitoylation of all 451 amino acids of alpha-tubulin. 3H-labeled palmitoylated alpha-tubulin was cleaved with cyanogen bromide (CNBr). The CNBr digest was resolved according to peptide size by gel filtration on Sephadex LH60 in formic acid:ethanol. The position of 3H-labeled palmitoylated amino acids in peptides could not be identified by analysis of the Edman degradation sequencer product because the palmitoylated sequencer products were lost during the final derivatization step to phenylthiohydantoin derivatives. Modification of the gas/liquid-phase sequencer to deliver the intermediate anilinothiozolinone derivative, rather than the phenylthiohydantoin derivative, identified the cycle containing the 3H-labeled palmitoylated residue. Therefore, structure analysis of peptides obtained from gel filtration necessitated dual sequencer runs of radioactive peptides, one for sequence analysis and one to identify 3H-labeled palmitoylated amino acids. Further cleavage of the CNBr peptides by trypsin and Lys-C protease, followed by gel filtration on Sephadex LH60 and dual sequencer runs, positioned the 3H-labeled palmitoylated amino acid residues in peptides. Integration of all the available structural information led to the assignment of the palmitoyl moiety to specific residues in alpha-tubulin. The palmitoylated residues in alpha-tubulin were confined to cysteine residues only. The major site for palmitoylation was cysteine residue 376.
如配套文章所示,微管蛋白在体内通过棕榈酰化进行翻译后修饰。本研究的目的是通过蛋白质结构分析确定棕榈酰化位点。为了获得该分析所需的大量棕榈酰化微管蛋白,我们在配套文章中开发并表征了一种用于酶促[3H]棕榈酰化的无细胞系统。然后,我们开发了一种方法来直接检测α-微管蛋白所有451个氨基酸的棕榈酰化情况。用溴化氰(CNBr)裂解3H标记的棕榈酰化α-微管蛋白。通过在甲酸:乙醇中的Sephadex LH60上进行凝胶过滤,根据肽大小分离CNBr消化产物。由于棕榈酰化的测序仪产物在最终衍生为苯硫代乙内酰脲衍生物的步骤中丢失,因此无法通过分析埃德曼降解测序仪产物来确定肽中3H标记的棕榈酰化氨基酸的位置。对气/液相测序仪进行改造,以提供中间的苯胺硫代唑啉酮衍生物,而不是苯硫代乙内酰脲衍生物,从而确定了含有3H标记的棕榈酰化残基的循环。因此,对从凝胶过滤获得的肽进行结构分析需要对放射性肽进行两次测序仪运行,一次用于序列分析,一次用于鉴定3H标记的棕榈酰化氨基酸。用胰蛋白酶和Lys-C蛋白酶进一步裂解CNBr肽,然后在Sephadex LH60上进行凝胶过滤和两次测序仪运行,确定了肽中3H标记的棕榈酰化氨基酸残基的位置。整合所有可用的结构信息,将棕榈酰部分定位到α-微管蛋白中的特定残基上。α-微管蛋白中的棕榈酰化残基仅限于半胱氨酸残基。棕榈酰化的主要位点是半胱氨酸残基376。